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This study evaluated the occurrence of enteric bacteria and pseudomonads resistant to tetracycline and -lactams in the oral cavity of patients exhibiting gingivitis (n=89), 
periodontitis (n=79), periodontally healthy (n=50) and wearing complete dentures (n=41). 
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of -lactamases and tetracycline resistance were performed by using biochemical tests 
and PCR. Susceptibility tests were carried out in 201 isolates of enteric cocci and rods. 
Resistance to ampicillin, amoxicillin/clavulanic acid, imipenem, meropenem and tetracycli-
ne was detected in 57.4%, 34.6%, 2.4%, 1.9% and 36.5% of the isolates, respectively. 
-lactamase production was observed in 41.2% of tested microorganisms, while the most 
commonly found -lactamase genetic determinant was gene blaTEM. Tetracycline resistance 
was disseminated and a wide scope of tet genes were detected in all studied microbial genus.
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INTRODUCTION
The oral microbiota is composed of more than 
500 different microbial species, most of them 
associated with oral health. However, sometimes 
the balance between the host’s immune system 
and microbial virulence is lost and opportunistic 
infections may arise. Hence, oral infectious 
diseases have been frequently associated with 
alterations in the host’ immune system, poor oral 
hygiene, denutrition, and alcoholism18.
Associations between the occurrence of 
opportunistic and superinfecting pathogens 
with patients exhibiting different periodontal 
status2 or wearing complete dentures4 have 
been established. However, the role enteric 
bacteria and pseudomonads play in the etiology 
of periodontal disease needs further studies. In 
edentulous patients wearing complete dentures, 
the presence of enteric microorganisms may be 
associated with development of mucositis and 
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Suppression of the oral microbiota by abusive 
or intensive use of antibiotics may facilitate 
a persistent colonization of the oral cavity by 
these opportunistic microorganisms18. These 
microorganisms may spread to microbial 
populations in nosocomial infections or to the 
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resistance genes7.
Tetracyclines were among the most widely 
used drugs in dentistry in the 80´s. Their 
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effects on anaerobes and Aggregatibacter 
actinomycetemcomitans made these drugs 
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periodontitis and necrotizing periodontitis. 
â-lactams, such as ampicillin, amoxicillin, 
cefoxitin and others constitute the basis of 
antimicrobial treatment of head and neck 
infections. However, microbial resistance to 
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this therapy and the dissemination of resistance 
genes among oral microorganisms needs further 
investigation, as the oral cavity may harbor 
some multiresistant microorganisms, particularly 
enteric rods and cocci.
Thus, the aim of this study was to evaluate 
the presence of antimicrobial resistance 
genes (tetracycline and -lactams) in enteric 
microorganisms isolated from the oral cavity 
of patients with gingivitis, periodontitis, 
periodontally healthy patients and patients 
wearing complete dentures, determining the 
distribution of most common -lactamase 
markers and tetracycline resistance markers.
MATERIAL AND METHODS
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Enteric microorganisms were isolated from 
250 patients (84 males and 166 females), mean 
age 43.03 years, within an 10-year follow-up 
period (1998-2008) at the School of Dentistry of 
Araçatuba, São Paulo State University (UNESP), 
Brazil. Forty-one patients wore complete 
dentures, 89 exhibited gingivitis, 70 chronic 
periodontitis and 50 were periodontally healthy. 
A written consent form was signed by all patients 
included in this study, which was approved by the 
Institutional Review Board of School of Dentistry 
of Araçatuba (Proc.27/2000 and 34/2006).
Microbial isolation was performed as previously 
described6

	





staining, colony morphology on agar plates, 
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(BioMérieux, Marcy le' Etoile, France). A total of 
201 enteric microorganisms and pseudomonads 
were submitted to susceptibility tests, as follows: 
Burkholderia cenocepacia (5 isolates), Citrobacter 
freundii (7 isolates), Enterobacter cloacae (18 
isolates), E. intermedius (6 isolates), E. sakazakii 
(9 isolates), Enterococcus sp. (18 isolates), E. 
faecalis (31 isolates), E. faecium (8 isolates), 
Escherichia coli (6 isolates), Klebsiella oxytoca (11 
isolates), K. pneumoniae (3 isolates), Morganella 
morganii (17 isolates), Pantoea agglomerans 
(7 isolates), Proteus mirabilis (5 isolates), P. 
vulgaris (7 isolates), Providencia alcalifaciens 
(6 isolates), Pseudomonas aeruginosa (15 
isolates), P. 	 (4 isolates), Serratia 
sp. (9 isolates), and S. liquefaciens (9 isolates).
All isolates were examined for susceptibility 
to tetracycline, ampicillin, amoxicillin/clavulanic 
acid, cefoxitin, cephalothin, imipenem and 
meropenem by the agar dilution method. When 
the Clinical Laboratory and Standards Institute 
(CLSI) antimicrobial breakpoints were not 
established, the breakpoints adopted by the 
British Society for Antimicrobial Chemotherapy 
(BSAC) were followed. Mueller-Hinton agar 
(MHA) was used for all isolates. 
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each bacterial strain were inoculated into 2 ml of 
sterile Mueller Hinton broth and incubated at 37°C 
for 12-24 h. Then, the turbidity was adjusted to 
match the 0.5 McFarland turbidity standard. The 
bacterial inocula were standardized in 105 cells 
and transferred to Mueller-Hinton agar plates 
containing the antimicrobial agent and control 
plates (without drugs), using a Steer’s replicator 
(Cefar Ltda., SP, Brazil). The test and control 
agar plates were incubated aerobically at 37ºC, 
for 48 h.
Antimicrobials were tested in two-fold dilution 
series ranging from 0.06 μg/mL to 256 μg/mL. 
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as sensitive or resistant, according to CLSI and 
BSAC guidelines. E. coli ATCC 25922, S. aureus 
ATCC 29213, P. aeruginosa ATCC 27853, and 
E. faecalis ATCC 29212 were used in the assays 
involving facultative anaerobes. 
Detection of -lactamases
-Lactam-resistant isolates were also tested 
for -lactamase activity by both chromogenic 
cephalosporin and biological method5. These two 
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useful in detecting -lactamase production by 
some microorganisms. In all tests, S. aureus 
ATCC 29213 was used as the positive control for 
-lactamase production.
Distribution of antimicrobial resistance 
determinants
Bacterial DNA from each -lactamase producers 
placed in sterile ultra-pure water was obtained 
by using a QIAamp DNA Mini Kit (Qiagen, Hilden, 
Germany). DNA concentrations were determined 
with a spectrophotometer at A260nm (Model DU-
640, Beckman Instruments, Richmond, Wash, 
USA).
Tetracycline-resistant isolates were screened 
for tetracycline resistance genes1,16 tet(A), 
tet(B), tet(C), tet(D), tet(E), tet(G), tet(K), 
tet(L), tet(M), tet(O), tet(Q), tet(S), and tet(T), 
while -lactam-resistant microorganisms were 
screened for blaTEM, blaCTX-M and blaSHV genes
3,8 
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performed in a DNA thermal cycler (AmpliTherm 
Thermal Cycler, Madison, WI, USA). The 
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initial denaturation, followed by 35 cycles at 94oC 
for 1 min, annealing temperature adequate for 
each primer pair for 1 min and 72oC for 1 min 
for extension; then 72o<
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DNA extension.
RESULTS
In relation to susceptibility to antimicrobial 
drugs, significant levels of resistance were 
observed for all -lactams, except for imipenem 
and meropenem, which presented 2.4% and 
1.9% of resistance, respectively. Resistance 
to ampicillin, and cephalothin were detected in 
57.4%, and 41.7% of tested bacteria, especially 
Pseudomonadaceae and Enterobacteriaceae. Out 
TAXON (N)            Resistance prevalence   N (%)      -lactamase
                            production  
       AM   AMC  CF   CP   IM   ME   TE
 
A. bamanii (10)    6 (60.0) 1 (10.0) 2 (20.0) 3 (30.0) 0 (0.0)  0 (0.0)  2 (20.0) 6 (60.0) 
B. cenocepacia (5)   4 (80.0) 2 (40.0) 1(20.0)  1 (20.0) 0 (0.0)  0 (0.0)  2 (40.0) 2 (40.0) 
C. freundii (7)    4 (57.1) 2 (28.6) 3 (42.9) 3 (42.9) 0 (0.0)  0 (0.0)  2 (28.6) 4 (57.1) 
E. cloacae (18)    14 (77.8) 9 (50.0) 11 (61.1) 11 (61.1) 0 (0.0)  0 (0.0)  1 (5.6)  13 (72.2)
E. intermedius (6)   2 (33.3) 2 (33.3) 0 (0.0)  0 (0.0)  0 (0.0)  0 (0.0)  1 (16.7) 2 (33.3) 
E. sakazakii (9)    4 (44.4) 1 (11.1)  2 (22.2) 9 (100.0) 0 (0.0)  0 (0.0)  1 (11.1)  4 (44.4) 
Enterococcus sp. (18)  4 (22.2) 0 (0.0)  6 (33.3) 7 (38.9) 0 (0.0)  0 (0.0)  7 (38.9) 0 (0.0) 
E. faecalis (31)    6 (19.4) 0 (0.0)  3 (9.7)  12 (38.7) 0 (0.0)  0 (0.0)  19 (61.3) 0 (0.0) 
E. faecium (8)    4 (50.0) 0 (0.0)  4 (50.0) 4 (50.0) 2 (25.0) 1 (12.5) 3 (37.5) 0 (0.0) 
E. coli (6)     4 (66.7) 1 (16.7) 0 (0.0)  0 (0.0)  0 (0.0)  0 (0.0)  1 (16.7) 4 (66.7) 
K. oxytoca (11)    7 (63.6) 5 (45.5) 1 (9.1)  3 (27.3) 0 (0.0)  0 (0.0)  0 (0.0)  6 (54.5) 
K. pneumoniae (3)   3 (100.0) 2 (66.7) 0 (0.0)  0 (0.0)  0 (0.0)  0 (0.0)  0 (0.0)  3 (100.0) 
M. morganii (17)   12 (70.6) 9 (52.9) 5 (29.4) 9 (52.9) 1 (5.9)  1 (5.9)  7 (41.2) 9 (52.9) 
P. agglomerans (7)   6 (85.7) 6 (85.7) 3 (42.9) 3 (42.9) 0 (0.0)  0 (0.0)  2 (28.5) 6 (85.7) 
P. mirabilis (5)    3 (60.0) 0 (0.0)  0 (0.0)  2 (40.0) 0 (0.0)  0 (0.0)  2 (40.0) 4 (80.0)
P. vulgaris (7)    5 (71.4) 2 (28.6) 1 (14.3) 1 (14.3) 0 (0.0)  0 (0.0)  1 (14.3) 5 (71.4) 
P. alcalifaciens (6)   4 (66.7) 4 (66.7) 1 (16.7) 2 (33.3) 0 (0.0)  0 (0.0)  4 (66.7) 4 (66.7) 
P. aeruginosa (15)   13 (86.7) 13 (86.7) 8 (53.3) 9 (60.0) 2 (13.3) 2 (13.3) 11 (73.3) 3 (20.0) 
	
	
(4)   3 (75.8) 3 (75.0) 0 (0.0)  1 (25.0) 0 (0.0)  0 (0.0)  1 (25.0) 1 (25.0) 
S. liquefaciens (9)   6 (66.7) 6 (66.7) 2 (22.2) 3 (33.3) 0 (0.0)  0 (0.0)  5 (55.6) 6 (66.7) 
Serratia sp. (9)    7 (77.8) 5 (55.6) 5 (55.6) 5 (55.6) 0 (0.0)  0 (0.0)  5 (55.6) 6 (66.7) 
Total (211)     121 (57.4) 73 (34.6) 58 (27.5) 88 (41.7) 5 (2.4)  4 (1.9)  77 (36.5) 87 (41.3)
Table 1- Resistance to -lactams and tetracycline in enteric bacteria and pseudomonads
AM= ampicillin; AMC= amoxicillin/clavulanic acid; CF= cefoxitin; CP= cephalotin; IM= imipenem; ME= 
meropenem; TE= tetracycline
RAMOS MMB, GAETTI-JARDIM EC, GAETTI-JARDIM E Jr
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of 121 bacterial isolates resistant to ampicillin 
or amoxicillin, 87 were -lactamase producers 
of (41.2% of the isolated bacteria and 72.9% of 
ampicillin-resistant isolates). The production of 
these hydrolytic enzymes seems to be the major 
mechanism of resistance to -lactams, excluding 
most pseudomonads, and enterococci, where 
-lactamases were not detected (Table 1).
Most of -lactamase Gram-negative producers 
harbored -lactamases. The detection of 
antimicrobial resistance determinants evidenced 
that 29.9% of Gram-negative isolates resistant 
to ampicillin harbored blaTEM genes, while blaSHV 
and blaCTX-M were detected in 23.4% and 2.8% 
of the resistant isolates, respectively (Table 2). 
These genes were not detected in enterococci 
(Table 3). 
Resistance to tetracycline was also widely 
disseminated in the microbial enteric strains 
and 36.5% of tested microorganisms were 
resistant. The presence of tetracycline resistance 
determinants was widely disseminated among 
resistant Gram-negative isolates and enterococci. 
Tet(A) and tet(B) were the most common in 
Gram-negative bacteria; while tet(K), tet(M) and 
tet(O) were predominant in resistant enterococci. 
Tet(G), tet(Q) and tet(T) were not detected. 
Resistant             Frequency of antimicrobial resistance determinants N(%) 
microorganisms   blaTEM  blaCTX-M  blaSHV  tet(A)  tet(B)  tet(C)  tet(D)  tet(E)  tet(M) 
A. bamanii     3 (50.0) 0 (0.0)  3 (50.0) 0 (0.0)  2 (100.0) 0 (0.0)  0 (0.0)  0 (0.0)  0 (0.0) 
B. cenocepacia    0 (0.0)  0 (0.0)  1 (50.0) 0 (0.0)  0 (0.0)  0 (0.0)  0 (0.0)  0 (0.0)  0 (0.0) 
C. freundii     1 (25.0) 0 (0.0)  1 (25.0) 1(50)  0 (0.0)  0 (0.0)  1 (50.0) 0 (0.0)  0 (0.0) 
E. cloacae     5 (35.7) 1 (7.1)  3 (21.5) 0 (0.0)  1 (100.0) 0 (0.0)  0 (0.0)  0 (0.0)  0 (0.0) 
E. intermedius    2 (100.0) 0 (0.0)  0 (0.0)  0 (0.0)  1 (100.0) 0 (0.0)  0 (0.0)  0 (0.0)  0 (0.0) 
E. sakazakii    2 (50.0) 0 (0.0)  2 (50.0) 0 (0.0)  0 (0.0)  1 (100.0) 0 (0.0)  0 (0.0)  0 (0.0) 
E. coli      1 (25.0)  0 (0.0)  0 (0.0)  0 (0.0)  0 (0.0)  0 (0.0)  0 (0.0)  1 (100.0) 0 (0.0) 
K. oxytoca     1 (14.3) 1 (14.3) 1 (14.3) 0 (0.0)  2 (100.0) 0 (0.0)  0 (0.0)  0 (0.0)  0 (0.0) 
K. pneumoniae    0 (0.0)  0 (0.0)  3 (75.0) 0 (0.0)  0 (0.0)  2 (100)  0 (0.0)  0 (0.0)  0 (0.0) 
M. morganii    7 (58.3) 1 (8.3)  4 (33.3) 1 (14.3) 3 (42.9) 0 (0.0)  0 (0.0)  0 (0.0)  0 (0.0) 
P. agglomerans    0 (0.0)  0 (0.0)  4 (66.7) 0 (0.0)  2 (100.0) 0 (0.0)  0 (0.0)  0 (0.0)  0 (0.0) 
P. mirabilis     0 (0.0)  0 (0.0)  1 (25.0) 1(50.0)  0(0.0)  0 (0.0)  0 (0.0)  0 (0.0)  1 (50.0) 
P. vulgaris     2 (40.0) 0 (0.0)  1 (20.0) 1(100.0) 0 (0.0)  0 (0.0)  0 (0.0)  0 (0.0)  0 (0.0) 
P. alcalifaciens    2 (50.0) 0 (0.0)  0 (0.0)  0 (0.0)  2 (50.0) 0 (0.0)  0 (0.0)  1 (25.0) 1 (25.0) 
P. aeruginosa    0 (0.0)  0 (0.0)  0 (0.0)  5 (54.5) 1 (9.09) 0 (0.0)  0 (0.0)  5 (45.45) 0 (0.0)
	
	
    0 (0.0)  0 (0.0)  0 (0.0)  1 (50.0) 0 (0.0)  0 (0.0)  0 (0.0)  1 (50.0) 0 (0.0) 
S. liquefaciens    2 (40.0) 0 (0.0)  1 (20.0) 3 (60.0) 0 (0.0)  0 (0.0)  2 (40.0) 0 (0.0)  0 (0.0) 
Serratia sp.     4 (57.1) 0 (0.0)  1 (14.3) 3 (60.0) 0 (0.0)  0 (0.0)  2 (40.0) 0 (0.0)  0 (0.0) 
Total      32 (29.9) 3 (2.8)  25 (23.4) 12 (25.0) 10 (20.8) 3 (6.3)  5 (10.4) 6 (12.5) 2 (4.2)
Table 2- Distribution of tetracycline and -lactam resistance genes in resistant Gram-negative isolates
Resistant strains        Frequency of antimicrobial resistance determinants N (%) 
       blaTEM/ blaCTX-M/ blaSHV      
               tet (K)   tet (L)   tet (M)   tet (O)   tet (S) 
Enterococcus sp.     0 (0.0)     3 (42.9)  1 (14.3)  2 (28.6)  1 (14.3)  0 (0.0) 
E. faecalis       0 (0.0)     6 (31.6)  2 (10.5)  7 (36.8)  3 (15.8)  1 (5.3) 
E. faecium      0 (0.0)     3 (66.7)  0 (0.0)   1 (33.3)  0 (0.0)   0 (0.0) 
Total        0 (0.0)     10 (34.5)  1 (3.5)   7 (24.1)  2 (6.9)   3 (10.3)
Table 3-  Distribution of tetracycline, ampicillin and gentamicin resistance genes in enterococci resistant to these antimicrobials
Resistance to tetracycline and 	
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DISCUSSION
Enteric bacteria and pseudomonads have 
been involved in many oral and extra-oral 
infections, and some studies have evidenced that 
the oral cavity may act as a reservoir of enteric 
microorganisms and their virulence genes1,6,7. 
In spite of the small participation of enteric 
bacteria and pseudomonads in the total microbial 
load present in the gingival sulcus, supragingival 
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the occurrence of these pathogens should not be 
neglected7. Antimicrobial resistance surveillance 
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antimicrobial susceptibility of clinically relevant 
enteric bacteria and pseudomonads from 
nosocomial infections and environment14,17, 
although few reports describe the antimicrobial 
susceptibility of these organisms isolated from 
the oral cavity2. In addition, information about 
the genetic determinants associated with this 
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data regards nosocomial infections, as mentioned 
above. 
-Lactam agents such as penici l l ins, 
cephalosporins, monobactams and carbapenems 
are among the most frequently prescribed 
antibiotics worldwide. In Gram-negative 
pathogens, -lactamases remain the most 
important factor to -lactam resistance, and their 
increasing prevalence, as well as their alarming 
evolution seems to be directly linked to their 
clinical use14.
In the present study, the genetic bases of 
-lactamase production in enteric Gram-negative 
rods were mainly associated with blaTEM gene, 
which evidenced a noticeable dissemination 
among Gram-negative enteric bacteria10,19. 
Presence of -lactamase genetic markers was 
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previously reported in literature, even though 
the distribution of particular determinants in 
-lactamase-producer strains was similar10,19.
However, the introduction of new -lactams 
with different activity spectra has led to a 
selection of different genes and mutations that 
confer resistance to these drugs, especially 
-lactamase-producers, mainly in members of 
family Enterobacteriaceae. In this family, most 
-lactamase producers harbor blaTEM, blaSHV and 
blaCTX-M resistance determinants
14. Thus, the 
distribution of these resistance markers in enteric 
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and mucosal surfaces remains unclear.
Therapeutic options for infections caused 
by Gram-negative organisms expressing 
-lactamases are limited because these organisms 
are usually resistant to all -lactam antibiotics, 
except the carbapenems. Several families of 
-lactamases from Gram-negative organisms 
were identified, but no phenotypic test can 
differentiate them, impairing surveillance and 
epidemiological studies13.
The genes screened in the -lactamase family 
represent only a small part of the cellular defense 
mechanisms that prokaryotes developed to avoid 
the action of -lactams. Enterobacteriaceae 
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by PCR were later classified as K. oxytoca, 
Enterobacter spp. and C. freundii due to detection 
markers of -lactam resistance8. Moreover, K. 
oxytoca
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class A -lactamases that were not considered 
in this study; while the resistance to -lactams 
in Enterobacter sp. and C. freundii is generally 
attributed to the expression of chromosomal 
AmpC -lactamases, as also described to some 
pseudomonads9. Possibly, these lactamases 
may be responsible for the -lactam resistance 
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
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
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		

#
spectrum cephalosporins, registered in some 
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
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
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Enterococci in general and E. faecium in 
particular, are intrinsically more resistant 
to penicillin and ampicillin than the other 
streptococci. Ampicillin resistance in E. faecium 
is due to expression 
 
 	#
 	

B penicillin-binding protein 5 (PBP5). Early 
studies suggested that higher levels of ampicillin 
resistance in E. faecium were achieved by 
increasing levels of PBP 5 expression. More 
commonly, mutations that are presumed to lower 

 
 
-lactam antibiotics have been 
 within pbp5 genes of highly resistant 
clinical isolates15. The results of the present 
investigation also suggested that enterococcal 
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resistance to -lactams, especially ampicillin, 
is not related to gene blaTEM, as this gene and 
-lactamase activities were not detected. 
Tetracycline resistance was also often 
observed. The most common genetic determinants 
of tetracycline resistance are represented by 
genes tet, which can be separated into genes 

 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tet(A), tet(B), tet(C), tet(D), tet(E), tet(G), 
tet(I), tet(K), and tet(L); those that protect 
the ribosomes from the action of tetracycline, 
genes tet(M) tet(O) tet(Q); and gene tet(X) that 
encodes a protein able to inactivate the antibiotic 
drug16. In Gram-positive cocci, the concomitant 
presence of two or more genes tet is common 

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present study, since only 5 isolates (17.2%) of 
enterococci expressed simultaneously tet(K) and 
tet(M) determinants.
In Enterobacteriaceae, the most common 
tetracycline resistance markers were tet(A) 
and tet(B), which were present in 45.8% of 
the  tetracycline resistant isolates, according to 
previous studies1,11,12,16. In enterococci, genes 
tet(K) and tet(M) represented 58.6% of the 
detected resistance markers.
Heterogeneity of tetracycline resistance genes 
in Gram-negative enteric rods and enterococci 

 
 
 	
 	
 11, 
although these genes were not detected in 18 
enteric resistant isolates. There are several 
possible explanations for the non-detection of 
tet genes in 23.4% of our resistant isolates. The 
most probable possibility is that we screened 
only 12 of the 38 recognized tet genes and 
some isolates present an inherent resistance to 
tetracycline as opposed to acquired resistance.
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